Skip to main content
. 2021 May 26;13:373–382. doi: 10.2147/CLEP.S304155

Table 3.

Prevalence of Dermatologic Comorbidity in People with (n = 933; Mean Age 44.6 Years) vs without (n = 120,850; Mean Age 43.1 Years) Vitiligo, Nonadjusted Data Among Working People in German Companies

Participants with Vitiligo Participants without Vitiligo
% 95% CI % 95% CI
Inflammatory skin diseases
Seborrhoeic dermatitis 4.4 3.15–5.96 3.1 2.97–3.17
Rosacea 2.3 1.39–3.44 2.2 2.12–2.29
Psoriasis 1.8 1.06–2.92 2.0 1.95–2.11
Atopic dermatitis 1.8 1.06–2.92 1.4 1.31–1.44
Acne 1.5 0.82–2.52 3.2 3.08–3.28
Exsiccation dermatosis 1.3 0.66–2.25 0.8 0.72–0.82
Intertriginous dermatitis 1.0 0.44–1.83 0.7 0.65–0.75
Hand eczema 1.0 0.44–1.83 0.9 0.82–0.92
Contact dermatitis 0.4 0.12–1.10 0.2 0.15–0.20
Viral diseases of the skin
Verruca vulgaris feet 2.7 1.73–3.96 2.4 2.32–2.50
Verruca vulgaris hands 0.3 0.07–0.94 0.6 0.54–0.62
Fungal diseases of the skin
Onychomycosis 7.0 5.38–8.88 6.2 6.08–6.36
Tinea pedis 5.8 4.35–7.55 4.4 4.32–4.56
Pityriasis versicolor 1.2 0.59–2.11 1.0 0.95–1.06
Tinea corporis 0.3 0.07–0.94 0.4 0.37–0.44
Bacterial diseases of the skin
Folliculitis 8.5 6.70–10.55 8.4 8.27–8.59
Pyoderma 0.3 0.07–0.94 0.5 0.49–0.58
Vascular lesions of the skin
Haemangioma 44.5 40.30–48.97 42.6 42.21–42.95
Spider veins 21.1 18.27–24.28 20.7 20.41–20.92
Teleangiectasia 6.9 5.28–8.76 6.3 6.20–6.48
Port-wine stains 3.3 2.26–4.72 2.2 2.07–2.23
Nonmalignant noninflammatory skin changes
Fibromas 30.7 27.20–34.42 28.7 28.42–29.03
Solar lentigines 30.2 26.80–33.97 36.8 36.46–37.15
Ephelides 23.5 20.47–26.80 21.3 21.01–21.53
Seborrhoic keratosis 23.0 20.07–26.34 23.2 22.88–23.43
Histiocytoma 17.6 14.99–20.48 18.2 17.97–18.45
Café au lait spots 5.9 4.44–7.67 6.3 6.11–6.39
Lipoma 2.0 1.23–3.18 1.4 1.34–1.48

Note: Significant group differences in bold.

Abbreviation: CI, confidence interval.